Healthier Capital, Norwest, Define Ventures and other new strategic investors back Hyro as demand soars for healthcare-native AI agents across providers, payers and clinics
Hyro, a leader in responsible AI agent technology for the healthcare industry, has announced a $45 million growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and existing investors. The funding also includes new strategic backing from Bon Secours Mercy Health, one of Hyro’s long-standing partners, and ServiceNow Ventures, the investment division of ServiceNow. This round comes less than a year after the company’s previous raise and effectively doubles its valuation, bringing total funding to $95 million. The capital infusion will help accelerate the development of AI-driven administrative, operational, and clinical agents that simplify patient access and improve digital experiences across communication channels.
Health Technology Insights: ENHERTU Plus THP Yields 67% Complete Response in HER2+ Breast Cancer
Hyro’s platform is already implemented across more than 45 major health systems in the United States, including Sutter Health, Tampa General Hospital, Prisma Health, and Piedmont Healthcare. More than 30 million patients nationwide currently use Hyro’s conversational and voice AI tools. The company is expanding its reach to health plans, mid-sized specialty practices, and clinical groups through new features such as Proactive Px™, a recently launched capability that enables two-way digital communication and anticipates patient needs before they arise.
As patient expectations shift toward faster, digital-first interactions, healthcare providers face increasing operational strain due to workforce shortages and rising administrative workloads. Hyro aims to bridge that gap by offering AI agents designed specifically for healthcare. These agents integrate seamlessly with electronic medical records, scheduling systems, and other enterprise tools, providing a deeply connected, compliant, and reliable experience.
Health Technology Insights: Ferring Shares New Real-World REBYOTA Data Boosting Patient Quality Of Life
Israel Krush, CEO and Co-Founder of Hyro, said the new funding reflects both confidence in the company’s approach and the urgency of its mission. He explained that healthcare organizations need AI solutions that are ready for real-world deployment and capable of handling sensitive data while aligning with established workflows. Krush added that with support from new and long-term partners, Hyro is positioned to expand into new specialties and segments across the healthcare ecosystem.
Amir Dan Rubin, CEO and Founding Managing Partner at Healthier Capital, noted that Hyro’s technology is delivering measurable improvements in patient access, operational efficiency, and overall experience for healthcare organizations. He said the company’s results, along with its trusted relationships and advanced platform, demonstrate a strong ability to create meaningful value at scale.
Assaf Harel, Partner at Norwest, emphasized that healthcare requires more than visually appealing AI tools. According to him, the industry needs intelligent systems that integrate with complex workflows inside hospitals and clinics. He believes Hyro has proven its ability to do this effectively and is on track to become a foundational layer for healthcare communication.
Staci Lucius, President of the Medical Group, Urgent Care, and Employer Services at Bon Secours Mercy Health, shared that her organization has worked with Hyro for over five years and will expand its use of the company’s AI scheduling solutions later this year. Cyril Philip, Vice President of Digital Ventures at Bon Secours Mercy Health and Accrete Health Partners, added that their continued investment in Hyro represents a commitment to improving access to care through innovative collaboration.
Hyro’s proprietary platform combines large language models with specialized conversational engines and small language models tailored for healthcare applications. It also uses advanced knowledge graphs to ensure accuracy, safety, and compliance. The system resolves up to 85 percent of routine patient interactions, such as appointment scheduling, registration, and prescription management, while maintaining strict adherence to HIPAA and other healthcare standards. When human assistance is required, Hyro’s system enables smooth handoffs to live agents without losing context.
The platform’s analytics dashboard provides real-time visibility into performance metrics and patient engagement trends, allowing healthcare organizations to monitor efficiency and AI effectiveness continuously.
With this funding, Hyro plans to continue enhancing its technology and expanding its partnerships across the healthcare sector. Its goal is to make AI a trusted, accessible, and integral part of patient communication, helping providers deliver better experiences while reducing operational burdens.
Health Technology Insights: Spring Health Launches VERA-MH for AI Validation in Mental Health
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
